5 . € million 2021 31.12.2020 Acquisitions/ Depreciation Disposals/ Reversals Changes in the scope of consolidation Other movements (1) 31.12.2021 Brands with indefinite useful life (3) 2,200.4 100.6 2,301.0 Amortisable brands and product ranges 92.3 -2.4 4.2 94.1 Licences and patents 738.7 14.6 -8.7 19.6 1.3 765.5 Software 1,627.5 62.1 -104.3 -1.9 155.7 1,739.1 Customer relationships 563.6 0.5 -0.6 6.3 43.2 613.0 Others 218.1 261.1 -0.3 - -120.2 358.7 Gross value 5,440.6 338.3 -116.3 24.0 184.8 5,871.4 Brands with indefinite useful lif (2) 242.1 82.8 22.9 347.8 Amortisable brands and product ranges 73.6 3.2 -2.4 3.5 77.9 Licences and patents 180.1 21.8 -8.7 1.5 194.7 Software 1,114.1 193.7 -101.9 -2.1 25.4 1,229.2 Customer relationships 455.1 43.1 -0.6 39.0 536.6 Others 19.3 2.4 -0.3 1.1 22.5 Depreciation and provisions 2,084.3 347.0 -113.9 -2.1 93.4 2,408.7 OTHER INTANGIBLE ASSETS – NET 3,356.3 -8.7 -2.5 26.2 91.5 3,462.8 (1) Other movements mainly consisted of the impact of hyperinflation in Argentina and the positive change in exchange rates over the period totalling €102.2  million. (2) Including the impairment of the brand Magic (€83  million), due to the exacerbated competition on on the masks market in China and its consequence on the slippage in Business Plan. The Magic technology is in contrast successfully implemented globally on brands Garnier and L’Oréal Paris. (3) At end-2021, the gross value of brands with an indefinite useful life span breaks down as follows: Accumulated impairment losses relating to brands amounted to €137.1 million on Magic, €96.5 million on Clarisonic, €54.2 million on Softsheen-Carson, €46.0 million on Yue-Sai and €14.0 million on Biomedic at 31 December 2021. 311.6 232.9 211.6 180.5 137.7 110.2 106.3 99.8 81.1 829.3 2,301.0 Matrix IT Cosmetics CeraVe Kiehl’s Shu Uemura NYX Professional Makeup Mugler Azzaro Others Total Urban Decay 316 L ’ ORÉAL I UNIVERSAL REGISTRATION DOCUMENT 2021 2021 CONSOLIDATED FINANCIAL STATEMENTS Notes to the consolidated financial statements

Universal Registration Document - Page 318 Universal Registration Document Page 317 Page 319